Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01771822 · ClinicalTrials.gov registry record · Phase 1
Ibuprofen 5% Topical Gel CIPT
A Phase 1 study of Pain, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01771822: Completed Phase 1 study of Pain, sponsored by Pfizer.
NCT01771822 is a Phase 1 study of Pain that has completed, run by Pfizer. The registered enrollment target is 50 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01771822, a Phase 1 study of Pain, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause irritation after repeated topical application to the healthy skin of human subjects under controlled conditions.
Conditions Studied
Interventions
- DRUG Ibuprofen 5% topical gel
- DRUG Topical gel vehicle
- DRUG Sodium lauryl sulfate 0.2%
- DRUG Sodium chloride solution 0.9% (saline)
Study Locations (1)
New Jersey
- Pfizer Investigational Site - Carlstadt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
What the finished NCT01771822 record still lists
NCT01771822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Ibuprofen 5% topical gel is the first listed.
NCT01771822 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01771822 about?
NCT01771822 is a clinical study titled "Ibuprofen 5% Topical Gel CIPT". This study will determine the potential of Ibuprofen 5% Topical Gel and its vehicle gel to cause irritation after repeated topical application to the healthy skin of human subjects under controlled conditions.
What is the current status of trial NCT01771822?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2013-01. Estimated completion is 2013-02.
What conditions does trial NCT01771822 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01771822?
The interventions under investigation include: Ibuprofen 5% topical gel (DRUG), Topical gel vehicle (DRUG), Sodium lauryl sulfate 0.2% (DRUG), Sodium chloride solution 0.9% (saline) (DRUG).
Who is sponsoring clinical trial NCT01771822?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01771822 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01771822's enrollment target sits among peer trials
50 254th of 374 higher than 111 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia